What is it about?
This study reveals a sophisticated "tug-of-war" between the adeno-associated virus (AAV) and its host. We identified a protein phosphatase complex (PP4:SMEK1) that acts as a barrier to AAV replication and gene expression. To overcome this, the virus uses its replication (Rep) proteins to block the complex from reaching its targets, effectively neutralizing downstream targets such as KAP1 and RPA2. Interestingly, our research suggests these Rep proteins are even more efficient than previously thought; they appear to target a "super-complex" containing two different phosphatases (PP1 and PP4) simultaneously: hitting two birds with one stone.
Featured Image
Photo by Anirudh on Unsplash
Why is it important?
AAV is a leading tool in gene therapy, which aims to replace defective genes within patient’s cells. However, its full potential remains untapped due to gaps in our understanding of how the virus interacts with its host. By uncovering how AAV manipulates cellular regulators such as PP4:SMEK1, this work provides a blueprint for designing next-generation viral vectors. Ultimately, these insights could lead to more effective gene therapies and improved outcomes for patients.
Perspectives
Investigating this topic felt like uncovering a missing piece of the puzzle in the surprisingly understudied field of AAV biology. The link to protein phosphatases allowed us to collaborate closely with renowned experts in the phosphatase field, bridging two distinct areas of study. We hope this work inspires laboratories worldwide to refocus on the fundamental mechanisms of AAV, as these basic insights are essential to enhancing its translational impact.
Bram Vandewinkel
Katholieke Universiteit Leuven
Read the Original
This page is a summary of: The adeno-associated virus Rep proteins target PP4:SMEK1 by preventing substrate recruitment, PLoS Pathogens, March 2026, PLOS,
DOI: 10.1371/journal.ppat.1014025.
You can read the full text:
Contributors
The following have contributed to this page
